MedTrace Logo

American Ginseng for the Prevention of Moderate-severe Fatigue in Breast Cancer Patients

NCT03730298 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 290

Last updated 2019-03-15

No results posted yet for this study

Summary

Among the symptoms referred by cancer patients, cancer related fatigue (CRF) is one of the most disabling symptom with a relevant impact on the quality of life.

CRF can occur before, during and after anti-cancer treatment. The aim of the present study is to verify the efficacy of American Ginseng in preventing or reducing the intensity of moderate-severe CRF in breast cancer women receiving adjuvant chemotherapy with anthracyclines plus cyclophosphamide after surgery.

Conditions

  • Cancer Related Fatigue
  • Breast Cancer Female

Interventions

DIETARY_SUPPLEMENT

American Ginseng

cpr

OTHER

Placebo

cpr

Sponsors & Collaborators

  • Azienda Ospedaliera di Perugia

    collaborator OTHER

  • Associazione Umbra per la lotta Contro il Cancro

    collaborator UNKNOWN

  • Avanti Tutta Onlus

    collaborator UNKNOWN

  • Network Italiano Cure di Supporto in Oncologia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-29
Primary Completion
2020-05-31
Completion
2020-08-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03730298 on ClinicalTrials.gov